Mesa Laboratories, Inc. (MLAB) financial statements (2022 and earlier)

Company profile

Business Address 12100 W 6TH AVE
LAKEWOOD, CO 80228
State of Incorp. CO
Fiscal Year End March 31
SIC 3823 - Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q3
9/30/2021
Q2
6/30/2021
Q1
3/31/2021
Q4
12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments51,706278,294275,710263,865253,731241,924230,951
Cash and cash equivalents51,706278,294275,710263,865253,731241,924230,951
Receivables37,28922,63620,57823,78720,41018,56317,929
Inventory, net of allowances, customer advances and progress billings23,71912,11712,12211,17811,96511,83712,900
Inventory23,71912,11712,12211,17811,96511,83712,900
Prepaid expense   4,0825,3273,3442,719
Other undisclosed current assets8,2816,3576,9018373,8424,4575,257
Total current assets:120,995319,404315,311303,749295,275280,125269,756
Noncurrent Assets
Property, plant and equipment30,15222,39221,95121,99822,29522,30921,796
Intangible assets, net (including goodwill)558,208263,465272,405272,582286,587273,068271,474
Goodwill293,542159,977162,725160,841165,784156,365153,948
Intangible assets, net (excluding goodwill)264,666103,488109,680111,741120,803116,703117,526
Deferred income tax assets5941,86262361615,67311,45311,453
Other noncurrent assets11,7631,9792,2002,5301,8061,9772,254
Total noncurrent assets:600,717289,698297,179297,726326,361308,807306,977
TOTAL ASSETS:721,712609,102612,490601,475621,636588,932576,733
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,29218,94924,50722,15820,10412,21614,097
Accounts payable7,8274,4634,0454,4733,7511,8522,812
Accrued liabilities12,4878,8369,9228,2979,1654,7535,944
Employee-related liabilities13,9785,65010,5409,3887,1885,6115,341
Deferred revenue12,4839,7418,9418,7777,6466,7905,858
Business combination, contingent consideration, liability     527520
Other undisclosed current liabilities   1,648   
Total current liabilities:46,77528,69033,44832,58327,75019,53320,475
Noncurrent Liabilities
Long-term debt and lease obligation229,140168,917168,695145,675144,302142,945141,604
Long-term debt, excluding current maturities229,140168,917168,695145,675144,302142,945141,604
Liabilities, other than long-term debt49,46812,07811,34416,99036,78934,04232,420
Deferred income tax liabilities41,13411,64210,81416,27536,10333,09031,230
Other liabilities8,3344365307156869521,190
Total noncurrent liabilities:278,608180,995180,039162,665181,091176,987174,024
Total liabilities:325,383209,685213,487195,248208,841196,520194,499
Stockholders' equity
Stockholders' equity attributable to parent396,329399,417399,003406,227412,795392,412382,234
Common stock308,208302,234298,203317,652314,537309,935306,880
Accumulated other comprehensive income8,81914,98421,48716,11628,8957,7533,112
Retained earnings79,30282,19979,31372,45969,36374,72472,242
Total stockholders' equity:396,329399,417399,003406,227412,795392,412382,234
TOTAL LIABILITIES AND EQUITY:721,712609,102612,490601,475621,636588,932576,733

Income statement (P&L) ($ in thousands)

12/31/2021
Q3
9/30/2021
Q2
6/30/2021
Q1
3/31/2021
Q4
12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
Revenues54,69635,84034,92037,96434,17231,86029,941
Cost of revenue(26,069)(12,700)(12,709)(13,228)(13,519)(10,575)(9,973)
Gross profit:28,62723,14022,21124,73620,65321,28519,968
Operating expenses(31,139)(18,939)(19,088)(20,440)(20,631)(16,815)(16,770)
Operating income (loss):(2,512)4,2013,1234,296224,4703,198
Nonoperating income (expense)171342(1,705)596(5,749)(2,086)(2,816)
Other nonoperating income (expense)1,1891,157(831) (3,799)(152)(897)
Interest and debt expense(1,018)(815)(874)(2,221)(1,950)(1,934)(1,919)
Other undisclosed income from continuing operations before equity method investments, income taxes   8,024   
Income (loss) from continuing operations before equity method investments, income taxes:(3,359)3,72854410,695(7,677)450(1,537)
Other undisclosed income (loss) from continuing operations before income taxes1,018815874(5,803)1,9501,9341,919
Income (loss) from continuing operations before income taxes:(2,341)4,5431,4184,892(5,727)2,384382
Income tax expense (benefit)281(823)577(972)1,185295643
Net income (loss) available to common stockholders, diluted:(2,060)3,7201,9953,920(4,542)2,6791,025

Comprehensive Income ($ in thousands)

12/31/2021
Q3
9/30/2021
Q2
6/30/2021
Q1
3/31/2021
Q4
12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
Net income (loss):(2,060)3,7201,9953,920(4,542)2,6791,025
Comprehensive income (loss):(2,060)3,7201,9953,920(4,542)2,6791,025
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6,165)(6,503)5,371(12,779)21,1425,26213,052
Comprehensive income (loss), net of tax, attributable to parent:(8,225)(2,783)7,366(8,859)16,6007,94114,077

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: